Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma

Trial Overview

Am I Eligible?

Participating US Centers

Fred Hutchinson Cancer Research Center

This center is currently accepting patients.

Seattle, WA

ACCEPTING

This trial is currently open and accepting patients.



Additional Information
Trial Phase

Phase 1

Trial Enrollment

25 sparks required

Trial Sponsors
  • Fred Hutchinson Cancer Research Center
Trial Collaborators
  • Juno Therapeutics, Inc.
  • National Cancer Institute (NCI)
Trial Identifiers

Need Help?

(888) 828-2206

Weekdays 9am - 5pm EST

;